Chanelle founder invests €100k in Redesdale Group

Michael Burke has taken a stake in a firm that will seek to acquire or invest in early stage food and wellness businesses

Michael Burke: managing director of Chanelle Pharmaceuticals. Picture: Michael Dillon

Michael Burke, the founder of Chanelle Pharmaceuticals, has joined veteran financier John Conroy’s Redesdale Group as a shareholder.

Set up by Conroy, the Merrion Capital founder, and formerly called Acton Health & Wellness Fund, Redesdale Group is expected to close an initial funding round in the region of €25 million later this quarter, sources familiar with the venture said.

Burke has invested in the region of €100,000 as part of his involvement in the buyout ...